StocksMediumUpdated•Originally published 2 October 2026•Updated 2 October 2026•
1 min read
Cardinal Health and McKesson Extend CVS Health Distribution Deals Through 2032
Key Facts
1Cardinal Health extended its pharmaceutical distribution agreement with CVS Health through June 30, 2032.
2Cardinal Health reaffirmed its fiscal year 2027 non-GAAP EPS growth guidance of 13% to 15%.
Cardinal Health and McKesson extended their pharmaceutical distribution agreements with CVS Health through June 2032. McKesson reported that its partnership with CVS Health accounted for approximately 24% of its fiscal year 2026 consolidated revenues, while Cardinal Health reaffirmed its fiscal year 2027 non-GAAP EPS growth guidance of 13% to 15%.
CAH closed at $230.09 and CVS closed at $85.20 on October 1, 2026. These extensions provide long-term volume security across the pharmaceutical distribution sector, following a fiscal year 2026 where Cardinal Health recorded total revenue of $254.2 billion.